Tailoring antiviral therapy in hepatitis C
- PMID: 16628667
- DOI: 10.1002/hep.21194
Tailoring antiviral therapy in hepatitis C
Comment on
-
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy.Hepatology. 2006 May;43(5):954-60. doi: 10.1002/hep.21159. Hepatology. 2006. PMID: 16628671
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical